Trial intelligence / Profile preview

Sildenafil for Cardiac Dysfunction in Duchenne and Becker Muscular Dystrophy

NCT01168908Phase 2Terminated

Sponsor
Hugo W. Moser Research Institute at Kennedy Krieger
Start
Sep 2010
Primary completion
Jan 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ASP-001 in Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), sponsored by Hugo W. Moser Research Institute at Kennedy Krieger. Started Sep 2010; status: terminated.

02

Drugs

ASP-001
03

Conditions

Duchenne muscular dystrophy (DMD)Becker muscular dystrophy (BMD)

Beyond the preview

Go deeper on NCT01168908.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01168908.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call